Tools

LEADER 02154nam 2200469 i 4500

001 on1427100780;

003 OCoLC;

005 20240330134753.0;

006 m o d f ;

007 cr |||||||||||;

008 240316s2024 mdua o f000 0 eng c;

035 a| (Sirsi) o1427100780;

042 a| pcc;

049 a| ERE#;

074 a| 0507-E-01 (online);

086 0 a| HE 20.3202:H 99/18;

245 00 a| Hydroxyurea use for sickle cell disease.;

264 1 a| [Bethesda, Md.] :b| U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute,c| 2024.;

300 a| 1 online resource (2 unnumbered pages) :b| color illustrations.;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| NIH Publication ;v| no. 24-HL-8219;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| "February 2024.";

500 a| "Blood diseases & disorders education program.";

500 a| GPO Cataloging Record Distribution Program (CRDP).;

588 a| Description based on online resource; title from PDF caption (NHLBI, viewed March 5, 2024).;

650 0 a| Sickle cell anemiax| Treatment.=| ^A293023;

650 0 a| Antineoplastic agentsx| Therapeutic use.=| ^A1221;

650 0 a| Ureax| Derivativesx| Therapeutic use.=| ^A1468053;

710 2 a| National Heart, Lung, and Blood Institutee| issuing body.=| ^A10166;

775 08 i| Issued also as:t| Hydroxyurea use for sickle cell disease. Spanish. Uso de la hidroxiurea para la enfermedad de células falciformesw| (OCoLC)1428270290;

830 0 a| NIH publication ;v| no. 24-HL-8219.=| ^A2592;

856 40 u| https://purl.fdlp.gov/GPO/gpo2233997| 0;

922 a| BIBCONEWb| 20240316;

922 a| UNREPORTEDPUBSSTAFFb| 20240316;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6340024;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6340024-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 4/15/2024x| EDOCUMENTz| JERESOURCE;

Hydroxyurea use for sickle cell disease.

Other author	National Heart, Lung, and Blood Institute issuing body.
Format	Electronic
Publication	[Bethesda, Md.] : U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 2024.
Description	1 online resource (2 unnumbered pages) : color illustrations.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo223399
Subjects	Sickle cell anemia--Treatment. Antineoplastic agents--Therapeutic use. Urea--Derivatives. --Therapeutic use.

Series	NIH Publication ; no. 24-HL-8219 NIH publication ; no. 24-HL-8219. ^A2592
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	"February 2024."
General note	"Blood diseases & disorders education program."
General note	GPO Cataloging Record Distribution Program (CRDP).
Source of description	Description based on online resource; title from PDF caption (NHLBI, viewed March 5, 2024).
Other edition issued	Issued also as: Hydroxyurea use for sickle cell disease. Spanish. Uso de la hidroxiurea para la enfermedad de células falciformes
GPO item number	0507-E-01 (online)
Govt. docs number	HE 20.3202:H 99/18

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Hydroxyurea use for sickle cell disease.

Click here for more information about this title

Availability